Keywords: AstraZeneca, Brilique, Brilinta, UK, NICE, ACS, Blood thinner

UK’s NICE backs AstraZeneca’s new “clot-busting” drug Brilique to treat ACS

Article | 16 September 2011

Print This

In final draft guidance published today, the UK drugs watchdog the National Institute of Health and Clinical Excellence (NICE) has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in